Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo.

Abstract:

:Chemotherapy is an important treatment for ovarian cancer. However, conventional chemotherapy has inevitable drawbacks due to side effects from nonspecific biodistribution of the chemotherapeutic drugs. To solve such problem, targeted delivery approaches were developed. The targeted delivery approaches combine drug carriers with the targeting system and can preferentially bring drugs to the targeted sites. Follicle-stimulating hormone receptor (FSHR) is an ovarian cancer-specific receptor. By using a peptide derived from FSH (amino acids 33-53 of the FSH beta chain, named as FSH33), we developed a conjugated nanoparticle, FSH33-NP, to target FSHR in ovarian cancer. FSH33-NP was tested for recognition specificity and uptake efficiency on FSHR-expressing cells. Then, the antitumor efficiency of paclitaxel (PTX)-loaded FSH33-NP (FSH33-NP-PTX) was determined. FSH33-NP-PTX displayed stronger antiproliferation and antitumor effects compared with free PTX or naked PTX-loaded nanoparticles (NP-PTX) both in vitro and in vivo. In summary, this novel FSH33-NP delivery system showed very high selectivity and efficacy for FSHR-expressing tumor tissues. Therefore, it has good potential to become a new therapeutic approach for patients with ovarian cancer.

journal_name

Cancer Res

journal_title

Cancer research

authors

Zhang XY,Chen J,Zheng YF,Gao XL,Kang Y,Liu JC,Cheng MJ,Sun H,Xu CJ

doi

10.1158/0008-5472.CAN-08-4721

subject

Has Abstract

pub_date

2009-08-15 00:00:00

pages

6506-14

issue

16

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-08-4721

journal_volume

69

pub_type

杂志文章
  • Effect of growth on the estrogen receptor levels in MCF-7 cells.

    abstract::MCF-7 cells have been shown to contain estrogen receptor in several cell fractions following homogenization: nuclei, microsomes, and cytosol. The amount of 17 beta-estradiol-binding capacity found in each cellular compartment depended on the inclusion of detergent in homogenization buffers and on the use of 0.25 M suc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Brooks SC,Hansen ER,Saunders DE,Battelli MG,Shafie SM

    更新日期:1984-09-01 00:00:00

  • Influence of drug formulation on OATP1B-mediated transport of paclitaxel.

    abstract::Taxane antineoplastic agents are extensively taken up into hepatocytes by OATP1B-type transporters before metabolism and excretion. Because the biodistributional properties imposed upon these agents by different solubilizers drive clinically important pharmacodynamic endpoints, we tested the hypothesis that the in vit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3634

    authors: Nieuweboer AJ,Hu S,Gui C,Hagenbuch B,Ghobadi Moghaddam-Helmantel IM,Gibson AA,de Bruijn P,Mathijssen RH,Sparreboom A

    更新日期:2014-06-01 00:00:00

  • Transplantation system for determining the clonogenic survival of parenchymal hepatocytes exposed to ionizing radiation.

    abstract::An in vivo transplantation technique has been developed which can be utilized to determine the reproductive survival of parenchymal hepatocytes exposed either in vitro or in vivo to both physical and chemical genotoxic agents. We have used this assay system to determine the survival of liver cells exposed to sparsely ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jirtle RL,Michalopoulos G,McLain JR,Crowley J

    更新日期:1981-09-01 00:00:00

  • Immunotoxin resistance in multidrug resistant cells.

    abstract::Multidrug resistance (MDR) can be mediated, in part, by overexpression of P-glycoprotein (P-gp) and is characterized by broad resistance to several structurally, chemically, and pharmacologically distinct chemotherapeutic compounds. It has been hypothesized that immunological approaches to cytolysis may be used to ove...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: McGrath MS,Rosenblum MG,Philips MR,Scheinberg DA

    更新日期:2003-01-01 00:00:00

  • Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells.

    abstract::Retroviral-mediated delivery of the P140K mutant O(6)-methylguanine-DNA methyltransferase (MGMT(P140K)) into hematopoietic stem cells (HSC) has been proposed as a means to protect against dose-limiting myelosuppressive toxicity ensuing from chemotherapy combining O(6)-alkylating agents (e.g., temozolomide) with pseudo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0320

    authors: Milsom MD,Jerabek-Willemsen M,Harris CE,Schambach A,Broun E,Bailey J,Jansen M,Schleimer D,Nattamai K,Wilhelm J,Watson A,Geiger H,Margison GP,Moritz T,Baum C,Thomale J,Williams DA

    更新日期:2008-08-01 00:00:00

  • Nucleotide excision repair factor XPC enhances DNA damage-induced apoptosis by downregulating the antiapoptotic short isoform of caspase-2.

    abstract::XPC protein is a critical DNA damage recognition factor in nucleotide excision repair for which genetic deficiency confers a predisposition to cancer. In this study, we show that XPC has a function that is independent of its canonical function in DNA repair, potentially altering the interpretation of how XPC deficienc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-2774

    authors: Wang QE,Han C,Zhang B,Sabapathy K,Wani AA

    更新日期:2012-02-01 00:00:00

  • Dynamic imaging of emerging resistance during cancer therapy.

    abstract::One of the greatest challenges in developing therapeutic regimens is the inability to rapidly and objectively assess tumor response due to treatment. Moreover, tumor response to therapeutic intervention in many cases is transient, and progressive alterations within the tumor may mask the effectiveness of an initially ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3205

    authors: Lee KC,Hall DE,Hoff BA,Moffat BA,Sharma S,Chenevert TL,Meyer CR,Leopold WR,Johnson TD,Mazurchuk RV,Rehemtulla A,Ross BD

    更新日期:2006-05-01 00:00:00

  • Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1.

    abstract::Immunotherapy for breast cancer using cytotoxic T cells (CTL) is hindered by the lack of well-characterized breast cancer antigens that are expressed in most breast tumor cells and recognized by CD8+ CTL. A recently described breast tissue differentiation antigen, NY-BR-1, is expressed in >80% breast tumors and elicit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3529

    authors: Wang W,Epler J,Salazar LG,Riddell SR

    更新日期:2006-07-01 00:00:00

  • Effects of the antitumor agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one on the DNA of mouse L1210 cells.

    abstract::L1210 murine leukemia cells were treated in vitro with the novel antineoplastic agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one (M&B 39565), and its interaction with cellular DNA was assessed by alkaline elution. DNA interstrand cross-link and DNA-protein cross-link formation was quantifi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gibson NW,Erickson LC,Hickman JA

    更新日期:1984-05-01 00:00:00

  • Identification of a human homologue of the murine tumor rejection antigen GP96.

    abstract::A family of cell surface glycoproteins with a molecular weight of 96,000 (gp96) has recently been implicated in the individually distinct immunogenicity of chemically induced sarcomas of inbred mice. Rabbit antiserum to murine gp96 detects an antigenically related Mr 96,000 cell surface glycoprotein on two cultured hu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Srivastava PK,Old LJ

    更新日期:1989-03-15 00:00:00

  • Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.

    abstract::We have measured glutathione content in small tissue samples derived from biopsies of primary and metastatic human colon tumors and from colon cancer cell lines in tissue culture and xenografts in athymic mice. Measurements were performed using an enzymatic cycling assay designed to quantitate extremely low levels of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Berger SJ,Gosky D,Zborowska E,Willson JK,Berger NA

    更新日期:1994-08-01 00:00:00

  • EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.

    abstract::The RNA-binding protein PNO1 is critical for ribosome biogenesis, but its potential role in cancer remains unknown. In this study, online data mining, cDNA, and tissue microarrays indicated that PNO1 expression was higher in colorectal cancer tissue than in noncancerous tissue, and its overexpression was associated wi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-3238

    authors: Shen A,Chen Y,Liu L,Huang Y,Chen H,Qi F,Lin J,Shen Z,Wu X,Wu M,Li Q,Qiu L,Yu N,Sferra TJ,Peng J

    更新日期:2019-05-01 00:00:00

  • Host organ specifically determines cancer progression.

    abstract::In order to further understand the role of the host organ in tumor progression, we have transplanted into nude mice histologically intact human colon cancer tissue on the serosal layers of the stomach (heterotopic site) and the serosal layers of the colon (orthotopic site). Xenograft lines Co-3, which is well differen...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Togo S,Shimada H,Kubota T,Moossa AR,Hoffman RM

    更新日期:1995-02-01 00:00:00

  • CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.

    abstract::Emerging evidence indicates the presence of tumor-initiating cells (TIC) or cancer stem cells in osteosarcoma. However, no study has shown specific markers to identify osteosarcoma TICs with in vivo tumor formation ability. Additionally, there has been a lack of investigations gauging the contribution of osteosarcoma ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3463

    authors: Adhikari AS,Agarwal N,Wood BM,Porretta C,Ruiz B,Pochampally RR,Iwakuma T

    更新日期:2010-06-01 00:00:00

  • Oxidoreductase activities in normal rat liver, tumor-bearing rat liver, and hepatoma HC-252.

    abstract::Experiments were carried out to determine if the difference in rates of cell proliferation between normal and neoplastic cells may be related to altered levels of oxidative enzymes. Assays were performed using homogenates from hepatocellular carcinoma HC-252, a rapidly growing and moderately well-differentiated tumor;...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sun AS,Cederbaum AI

    更新日期:1980-12-01 00:00:00

  • Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.

    abstract::DR-nm23 cDNA was cloned recently by differential screening of a cDNA library derived from chronic myelogenous leukemia-blast crisis primary cells. It is highly homologous to the putative metastasis suppressor nm23-H1 gene and the closely related nm23-H2 gene. When overexpressed in the myeloid precursor 32Dcl3 cell lin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Martinez R,Venturelli D,Perrotti D,Veronese ML,Kastury K,Druck T,Huebner K,Calabretta B

    更新日期:1997-03-15 00:00:00

  • Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.

    abstract::The DNA intercalator, 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and the nonintercalator, etoposide (VP-16) produce topoisomerase II-mediated protein-linked DNA strand breaks. This function of topoisomerase II was investigated in relation to cell proliferation and cell cycle. Mouse fibroblasts NIH 3T3 and...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Markovits J,Pommier Y,Kerrigan D,Covey JM,Tilchen EJ,Kohn KW

    更新日期:1987-04-15 00:00:00

  • Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus.

    abstract::Linkage to a prostate cancer susceptibility locus was recently reported on chromosome 16q23. We now report a region exhibiting a high frequency of allelic imbalance (AI) corresponding to this locus in tumors from 51 men diagnosed with prostate cancer using the same linked markers. The highest frequency of AI was found...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Paris PL,Witte JS,Kupelian PA,Levin H,Klein EA,Catalona WJ,Casey G

    更新日期:2000-07-01 00:00:00

  • Genetic alterations in primary bladder cancers and their metastases.

    abstract::Bladder cancer progression is thought to be associated with sequential genetic events. To search for the specific genetic changes associated with the metastatic process, comparative genomic hybridization was performed on 22 primary tumors and 24 metastases (10 distant and 14 nodal metastases) from 17 patients with sta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hovey RM,Chu L,Balazs M,DeVries S,Moore D,Sauter G,Carroll PR,Waldman FM

    更新日期:1998-08-15 00:00:00

  • Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.

    abstract::The aggressive biology of human pancreatic adenocarcinoma has been linked with overexpression of vascular endothelial growth factor (VEGF). Constitutive activation of the transcription factor Sp1 plays a critical role in VEGF overexpression. Recent studies indicated that celecoxib, a selective cyclooxygenase-2 inhibit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-1945

    authors: Wei D,Wang L,He Y,Xiong HQ,Abbruzzese JL,Xie K

    更新日期:2004-03-15 00:00:00

  • BAG-1 prevents stress-induced long-term growth inhibition in breast cancer cells via a chaperone-dependent pathway.

    abstract::BAG-1 is a multifunctional protein that interacts with a wide range of cellular targets. There is accumulating evidence that overexpression of BAG-1 may play an important role in breast cancer; however, the functional consequences of BAG-1 expression and its mechanism of action in breast cancer cells have not been stu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Townsend PA,Cutress RI,Sharp A,Brimmell M,Packham G

    更新日期:2003-07-15 00:00:00

  • Differential characteristics of two newly established human breast carcinoma cell lines.

    abstract::Two human breast carcinoma cell lines, EP and MW, were established in culture from malignant pleural effusions. In addition to producing tumors in antithymocyte serum-immunosuppressed mice, both cell lines showed epithelial characteristics and anchorage-independent growth in soft agar. EP and MW differed in morphology...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chu MY,Hagerty MG,Wiemann MC,Tibbetts LM,Sato S,Cummings FJ,Bogaars HA,Leduc EH,Calabresi P

    更新日期:1985-03-01 00:00:00

  • Retinoic acid receptor beta induces terminal differentiation of squamous cell carcinoma lines in the absence of cyclin-dependent kinase inhibitor expression.

    abstract::The chemotherapeutic agent and vitamin A metabolite retinoic acid (RA) has been used to treat many tumor types. The effects of RA are mediated by a family of ligand-dependent transcription factors, the retinoic acid receptors (RAR) and the retinoid X receptors. Alterations in RAR expression have been implicated in tum...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Crowe DL

    更新日期:1998-01-01 00:00:00

  • Identification of an inactivating cysteine switch in protein kinase Cepsilon, a rational target for the design of protein kinase Cepsilon-inhibitory cancer therapeutics.

    abstract::Critical roles played by some protein kinases in neoplastic transformation and progression provide a rationale for developing selective, small-molecule kinase inhibitors as antineoplastic drugs. Protein kinase Cepsilon (PKCepsilon) is a rational target for cancer therapy, because it is oncogenic and prometastatic in t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1989

    authors: Chu F,Koomen JM,Kobayashi R,O'Brian CA

    更新日期:2005-11-15 00:00:00

  • Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.

    abstract::In spite of preclinical efficacy and recent randomized, controlled studies with adenoviral vectors expressing herpes simplex virus-1 thymidine kinase (HSV1-TK) showing statistically significant increases in survival, most clinical trials using single therapies have failed to provide major therapeutic breakthroughs. Be...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-3434

    authors: Ali S,King GD,Curtin JF,Candolfi M,Xiong W,Liu C,Puntel M,Cheng Q,Prieto J,Ribas A,Kupiec-Weglinski J,van Rooijen N,Lassmann H,Lowenstein PR,Castro MG

    更新日期:2005-08-15 00:00:00

  • Loss of annexin II heavy and light chains in prostate cancer and its precursors.

    abstract::Annexin II mRNA coding for a calcium binding protein was found to be absent in prostate cancer by subtractive hybridization and Northern analysis. In contrast to high expression in normal and benign hyperplastic glandular and basal epithelium, Annexin II heavy (p36) and light (p11) chains in 31/31 prostate cancer spec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chetcuti A,Margan SH,Russell P,Mann S,Millar DS,Clark SJ,Rogers J,Handelsman DJ,Dong Q

    更新日期:2001-09-01 00:00:00

  • Heterogeneous expression of keratin, involucrin, and extracellular matrix among subpopulations of a poorly differentiated human cervical carcinoma: possible relationships to patterns of invasion.

    abstract::Undifferentiated cervical carcinomas vary considerably in their intercellular organization and patterns of invasion. In spite of its clinical significance, the basis for such variation is poorly understood. We investigated the cellular properties that may be responsible for this diversity, using as a model two human c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Auersperg N,Kruk PA,MacLaren IA,Watt FM,Mydral SE

    更新日期:1989-06-01 00:00:00

  • Statistical analysis of in vivo tumor growth experiments.

    abstract::We review and compare statistical methods for the analysis of in vivo tumor growth experiments. The methods most commonly used are deficient in that they have either low power or misleading type I error rates. We propose a set of multivariate statistical modeling methods that correct these problems, illustrating their...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Heitjan DF,Manni A,Santen RJ

    更新日期:1993-12-15 00:00:00

  • Effects of the immunosuppressive drug niridazole in isogeneic and allogeneic mouse tumor systems in vivo.

    abstract::In both isogeneic (Sarcoma 1 in A/JAX mice) and allogeneic (Sarcoma 180 in C57BL/6 mice) mouse tumor systems, treatment of the tumor-bearing mice with niridazole, an antiprarasitic drug, known to be a potent suppressor of cell mediated but not humoral immunity caused enhancement of metastases to regional popliteal nod...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Deodhar SD,Lee VW,Chiang T,Mahmoud AF,Watten KS

    更新日期:1976-09-01 00:00:00

  • Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.

    abstract::Bcl-2 is upregulated by Epstein-Barr virus (EBV) in immortalized lymphoblastoid (LCL) B cells and is expressed in the majority of EBV-associated posttransplant lymphoproliferative disorders (PTLDs). Given the antiapoptotic function and chemoprotective effects of Bcl-2, it represents a rational target for modulation us...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Guinness ME,Kenney JL,Reiss M,Lacy J

    更新日期:2000-10-01 00:00:00